Check 35,000+ stocks against 26 valuation models and 37 quality factors

Procter & Gamble Company (PG) fair value: what the stock is really worth

We calculate from audited financials what Procter & Gamble Company is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Fair value above price? No
Good quality? Yes
Add to watchlist

Consumer Defensive · US · ISIN US7427181091

Broad data Sep 17, 2026

Procter & Gamble Company

PG · US

Great Company, Expensive PriceHigh Quality, but the stock trades above estimated Fair Value.

!Fair value $108.16 · Overvalued (−26%)

✓Quality 76/100

✓Healthy Growth (revenue 5y +3.5 %/yr)

✓Solidly profitable · 19.2% net margin (TTM)

✓Low debt · generates free cash flow

·2.89% dividend yield

!Mixed vs. peers (7/15)

✓Wide moat 87/100

!Insider activity 45/100

26 models, one by oneBear $70.77 to bull $151.46 Growth analysisrevenue history, year by year Quality 76/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Procter & Gamble Company for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 17, 2026.

How to read this chart

60‑month range $112.26 – $172.51 · fair‑value band $70.77 – $151.46 · the $146.39 price screens above the $108.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 17, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments.

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Stock analysis

Procter & Gamble Company (PG) currently trades at $146.39, while our model-based Fair Value estimate is $108.16, implying the stock looks roughly 35.4% overvalued today.

Valuation

Bull case: the Multiples group reads highest at a median of $116.62 per share, and 0 of the 24 models we run sit above the $146.39 price.

Bear case: the Asset-Based group reads lowest at $14.97, and 24 of the 24 models stay below the price. Evidence for this calculation is high.

Scenario range: $70.77 (bear) to $151.46 (bull), the price of $146.39 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 76/100 (high quality), in the Consumer Defensive sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Procter & Gamble Company reported revenue of $84.3B in FY2025 versus $76.1B in FY2021, a compound +2.6%/yr. Reported net income was $16.0B in FY2025, compounding +2.8%/yr from FY2021.

Key figures

Market cap $359B · P/E ratio 21.4 · P/S ratio 4.06 · EPS (TTM) $6.84 · Dividend yield 2.9% · Net margin 19.0% · Return on equity 31.1% · Return on assets (EBIT) 15.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 66 out of 100 (medium confidence).

What moves the price

The share trades about 12% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −32% fair-value upside, at −26%, PG screens cheaper than that median.

Fair Value models

Bear $70.77 Fair Value $108.16 Bull $151.46

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then ($2.61 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF $59.29 $87.68 $131.41 80

Growth DCF $61.84 $89.08 $129.29 78

Owner Earnings $64.01 $94.42 $141.28 76

All 24 models by family

DCF Models

FCF DCF $59.29 $87.68 $131.41 80

Owner Earnings $64.01 $94.42 $141.28 76

5Y Revenue Exit $39.62 $58.26 $81.32 73

5Y EBITDA Exit $71.50 $113.77 $161.73 75

5Y P/E Exit $77.39 $124.02 $171.17 71

10Y Revenue Exit $45.12 $63.08 $83.95 67

10Y EBITDA Exit $66.45 $101.04 $142.17 68

10Y P/E Exit $70.18 $108.05 $149.00 64

Earnings-Based

Graham-Dodd $46.65 $94.44 $118.88 66

EPV $63.58 $75.97 $86.98 74

Dividend Discount

Gordon GGM $40.78 $60.44 $81.76 68

DDM Multi-Stage $40.78 $58.66 $80.22 67

Multiples

P/E Multiple $108.04 $144.06 $180.07 63

P/S Multiple $43.43 $57.91 $72.39 58

P/B Multiple $87.46 $116.62 $145.77 55

EV/EBIT $105.35 $142.67 $180.00 66

EV/EBITDA $90.92 $123.44 $155.95 67

EV/Revenue $31.37 $47.66 $63.95 53

Asset-Based

NCAV (Graham) $11.17 $14.97 $22.34 54

Growth DCF

Growth DCF $61.84 $89.08 $129.29 78

Rev-Margin DCF $39.62 $59.33 $80.81 73

Economic Profit

Residual Income $43.98 $54.75 $243.92 64

ROIC Compounder $65.79 $81.65 $98.14 72

Growth Earnings

Growth-Adj P/E $78.55 $112.21 $145.87 67

Open the full fair value analysis →

Notify me when PG reaches fair value

Put PG on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 76/100

Of which business quality 71 · Market factors (momentum, volatility) 52

Profitability 73

Margins and returns on capital today

Quality Growth 46

Are margins and returns improving?

Cashflow 65

Earnings quality: real cash, not paper profit

Fin. Strength 70

Balance sheet, leverage, solvency risk

Investment 85

Disciplined investing over empire-building

Low Volatility 95

Calm price path (market factor)

Momentum 37

Price trend over the last 3–12 months (market factor)

52W Momentum 31

Distance to the 52-week high (market factor)

Net Issuance 91

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 75/100

Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Revenue growth 1 year

+0.3%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+1.7%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+3.5%

Revenue growth 39 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+4.4%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.

+8.5%

Earnings growth per share plus dividend.

Earnings per share, growth per year+5.6%

Dividend (yield on the price)2.9%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.6% vs 6%, steady

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22% → 24%

Growth Forecast

A lot of optimism in the price

The price assumes more growth than the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+9.2%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+2.9%

Yearly sales growth analysts expect, extended to five years.

Forecast 2026 (sales)+3.1%

Forecast 2027 (sales)+3.1%

Projected 2028 (sales)+2.9%

Projected 2029 (sales)+2.8%

Projected 2030 (sales)+2.7%

PG screens 35% overvalued. Compare with L'Oréal S.A →

Compare Procter & Gamble Company with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 249 stocks

Beats the industry median on 7/15 measures

A mixed picture versus its industry peers.

Valuation

Quality Score 76 · Top 25%

Fair Value upside −26% · Below median

Profitability

Return on equity (TTM) 31% · Top 25%

Return on assets 11% · Top 25%

Net margin (TTM) 19% · Top 25%

Operating margin (TTM) 23% · Top 25%

Growth and dividend

Revenue growth 7% · Above median

Dividend yield (TTM) 2.9% · Above median

Balance sheet

Debt / equity 0.48× · Highest 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/E (TTM) 21.4× · Pricier than median

P/B 6.58× · Priciest 25%

P/S (TTM) 3.95× · Priciest 25%

P/FCF 24.4× · Priciest 25%

EV/EBITDA 14.3× · Pricier than median

PEG 4.13× · Priciest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 33

FUTURE (revenue growth)37 · sector 9

PAST (return on equity)100 · sector 27

HEALTH (low debt)76 · sector 98

DIVIDEND (yield)58 · sector 55

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
L'Oréal S.A LORL	C$25.21	C$21.85	−13%
Unilever PLC UNA	€54.18	€40.47	−25%
Colgate-Palmolive Company CL	$87.02	$55.28	−36%
500696 500696	₹1,934	₹493.08	−75%
Hindustan Unilever Limited HINDUNILVR	₹1,962	₹789.46	−60%
Kenvue Inc KVUE	$17.83	$10.97	−38%
Kimberly-Clark Corporation KMB	$98.10	$79.71	−19%
Henkel AG HEN3	€73.30	€78.02	+6%
The Estée Lauder Companies Inc EL	$96.25	$21.04	−78%
Church & Dwight Co CHD	$95.51	$65.12	−32%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Procter & Gamble Company · Fair Value
$108.16 −35%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/PG" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Procter &amp; Gamble Company · Fair Value</span><br><b style="font-size:20px">$108.16</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−35%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Procter & Gamble Company Fair Value". https://www.fairvalue-calculator.com/stock/PG

Frequently asked questions

Is Procter & Gamble Company (PG) overvalued or undervalued?

As of Sep 17, 2026, our model estimates a fair value of $108.16 versus a price of $146.39, about −26% upside (overvalued).

What is the fair value of PG?

Our model-based fair value for Procter & Gamble Company is $108.16 (as of Sep 17, 2026), built from audited fundamentals. The current price: $146.39.

What is the quality score of PG?

Procter & Gamble Company has a Quality Score of 76/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Procter & Gamble Company (PG)?

Our model-based price target is the fair value of $108.16 (as of Sep 17, 2026) from 24 valuation models. Cautious scenario $70.77, optimistic scenario $151.46. It is a calculation from audited fundamentals, not an analyst target.

What is the Procter & Gamble Company stock forecast for 2026?

Our models put fair value at $108.16, about −26% upside versus a price of $146.39 (overvalued). Cautious scenario $70.77, optimistic scenario $151.46. The calculation is refreshed regularly with new filings.

What is the revenue of Procter & Gamble Company (PG)?

Procter & Gamble Company reported trailing-twelve-month revenue of about $86.7B (latest available figure, as of Sep 17, 2026).

Does Procter & Gamble Company pay a dividend?

Procter & Gamble Company currently shows a dividend yield of about 2.89% relative to its recent price (as of Sep 17, 2026).

What growth is priced into Procter & Gamble Company (PG)?

For today's price to be fair in a discounted-cash-flow model, Procter & Gamble Company would have to grow free cash flow by +9.2 % per year for five years (discount rate 7.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.5 % per year. As of Sep 17, 2026.

What discount rate (WACC) does the fair value of PG use?

Our models discount Procter & Gamble Company at 7.6 %: a base by market capitalisation (mega), damped by beta 0.40, country premium for USA. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Procter & Gamble Company that is +9.2 % per year a year over ten years, using the same discount rate (7.6 %) and the same formula as our fair value.

How much growth has Procter & Gamble Company (PG) delivered so far?

Over the past 5 years revenue at Procter & Gamble Company grew +3.5 % a year. The price currently implies +9.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Procter & Gamble Company (PG) growing?

The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into Procter & Gamble Company (+9.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Procter & Gamble Company (PG)?

The free-cash-flow yield on the price is 3.91 %: that much free cash flow Procter & Gamble Company produces per unit of market value. When it exceeds the discount rate of our models (7.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Procter & Gamble Company (PG)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Procter & Gamble Company it is $108.16 per share (as of Sep 17, 2026), against a price of $146.39. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).

Is Procter & Gamble Company stock overvalued or undervalued in 2026?

As of Sep 17, 2026, PG trades above its calculated fair value: price $146.39, fair value $108.16, a gap of about −26% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of PG?

No. The price is what the market pays today ($146.39); the fair value is what the company's own numbers justify ($108.16). For Procter & Gamble Company the two are $38.23 per share apart. That gap is exactly why we show both numbers side by side.

How much is Procter & Gamble Company worth?

The market values Procter & Gamble Company at about $359B (market capitalisation, as of Sep 17, 2026). Per share that is $146.39; our models calculate a fair value of $108.16 per share.

What do the bullish and bearish scenarios say about PG?

Our models span a range for Procter & Gamble Company: cautious scenario $70.77, base $108.16, optimistic $151.46 per share (as of Sep 17, 2026, price $146.39). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of PG?

Procter & Gamble Company trades at a price-to-earnings ratio of 21.4 (as of Sep 17, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $108.16 is built from several models across several years. Other multiples: PEG 4.1, P/B 6.6, P/S 3.9, EV/EBITDA 14.3.

What is the PEG ratio of PG?

The PEG ratio of Procter & Gamble Company is 4.13 (P/E divided by earnings growth, as of Sep 17, 2026). That is above 1, so the growth is already paid for in the price.

How solid is the balance sheet of Procter & Gamble Company (PG)?

Balance-sheet figures for Procter & Gamble Company (as of Sep 17, 2026): return on equity 31.1%, debt of 0.48 per unit of equity. They feed the Quality Score of 76/100, which measures business quality independently of the share price.

How far is PG from its 52-week high?

Procter & Gamble Company trades at $146.39, about 12% below its 52-week high of $166.00 and 8% above the low of $135.63 (as of Sep 17, 2026). Distance from the high says nothing about value: that is what the fair value of $108.16 is for.

Which stocks are comparable to Procter & Gamble Company?

From the same area (Consumer Defensive) we also value L'Oréal S.A, Unilever PLC, Colgate-Palmolive Company, 500696, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Procter & Gamble Company stock attractive at the current price?

The data as of Sep 17, 2026: price $146.39, calculated fair value $108.16 (−26%), Quality Score 76/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of PG calculated?

We run Procter & Gamble Company through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $108.16, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 16.1 % above its aggregate fair value. Procter & Gamble Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Procter & Gamble Company (PG)?

The closing price on Sep 18, 2026 was $146.39. Our model-based fair value is $108.16, about −26% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Procter & Gamble Company right now?

A high-quality business (quality 76/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. A fairly wide model range ($70.77 to $151.46) leaves room in how you read the outcome.

Where does the earnings growth of Procter & Gamble Company (PG) come from?

Earnings per share at Procter & Gamble Company grew +6.9 % a year from 2014 to 2025. Broken into its drivers: revenue per share +3.7 %, EBIT margin +2.5 %, tax rate +0.5 %, residual (interest, one-offs) +0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Procter & Gamble Company

How large is the market capitalisation of Procter & Gamble Company (PG)?

The market capitalisation of Procter & Gamble Company is $359B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Procter & Gamble Company (PG)?

The price-to-sales ratio of Procter & Gamble Company is 4.06 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Procter & Gamble Company (PG)?

Earnings per share at Procter & Gamble Company are $6.84 (price ÷ EPS = P/E 21.4). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Procter & Gamble Company (PG)?

The dividend yield of Procter & Gamble Company is 2.9% (payout 61.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Procter & Gamble Company (PG)?

The net margin of Procter & Gamble Company is 19.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Procter & Gamble Company (PG)?

The return on equity (ROE) of Procter & Gamble Company is 31.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Procter & Gamble Company (PG)?

On an EBIT basis the return on assets of Procter & Gamble Company is 15.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Procter & Gamble Company (PG)?

The operating margin of Procter & Gamble Company is 23.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Procter & Gamble Company (PG)?

Revenue at Procter & Gamble Company is growing +7.4% versus a year earlier (3y avg +1.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Procter & Gamble Company (PG)?

Earnings per share at Procter & Gamble Company are growing +5.8% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Procter & Gamble Company (PG) carry?

The net debt of Procter & Gamble Company is $25.9B (fiscal year 2025, ≈ 1.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Procter & Gamble Company in the live analysis

One click puts Procter & Gamble Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.